Research Paper Volume 16, Issue 4 pp 4033—4051
LGALS3BP is a novel and potential biomarker in clear cell renal cell carcinoma
Figure 8. The clinical and molecular features associated with the stemness index (mRNAsi) in ccRCC patients. (A) An overview of the association between mRNAsi and clinicopathological features of patients. Columns represent samples ranked by mRNAsi from low to high (top row), and rows represent known clinical and molecular characteristics associated with mRNAsi. (B) The cancer stemness index of the tumor metastasis group was significantly higher than that of the normal group (p <0.05).